{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T05:43:15Z","timestamp":1770010995503,"version":"3.49.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.pbb.2005.06.010","type":"journal-article","created":{"date-parts":[[2005,7,20]],"date-time":"2005-07-20T20:08:37Z","timestamp":1121890117000},"page":"879-886","source":"Crossref","is-referenced-by-count":34,"title":["Effects of donepezil, nicotine and haloperidol on the central serotonergic system in mice: Implications for Tourette's syndrome"],"prefix":"10.1016","volume":"81","author":[{"given":"Renee L.","family":"Hayslett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Tizabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2005.06.010_bib1","first-page":"1066","article-title":"Selective and divergent regulation of cortical 5-HT2A receptors in rabbit","volume":"299","author":"Aloyo","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.06.010_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1471-4159.1986.tb12944.x","article-title":"Differential effect of subchronic treatment with various neuroleptic agents on serotonin-2 receptors in rat cerebral cortex","volume":"46","author":"Andree","year":"1986","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2005.06.010_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-0773.1984.tb01996.x","article-title":"The citalopram\/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters","volume":"55","author":"Arnt","year":"1984","journal-title":"Acta Pharm Toxicol"},{"key":"10.1016\/j.pbb.2005.06.010_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/026988119500900311","article-title":"Neurochemical and some related psychopharmacological aspects of Tourette's syndrome: an update","volume":"9","author":"Baker","year":"1995","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2005.06.010_bib6","first-page":"303","article-title":"Serotonin receptor sensitivity after acute and chronic treatment with mianserin","volume":"221","author":"Blackshear","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.06.010_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00497017","article-title":"Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites","volume":"324","author":"Blackshear","year":"1983","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pbb.2005.06.010_bib7","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0028-3908(86)90146-2","article-title":"Adaptive changes in the 5-HT2 binding site after chronic administration of agonists and antagonists","volume":"25","author":"Blackshear","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2005.06.010_bib8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archpsyc.1980.01780250029002","article-title":"Sensory experiences of Gille de la Tourette syndrome","volume":"37","author":"Bliss","year":"1980","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2005.06.010_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-328X(97)00076-4","article-title":"The effects of antipsychotic drugs on the mRNA levels of serotonin 5HT2A and 5HT2c receptors","volume":"48","author":"Buckland","year":"1997","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pbb.2005.06.010_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0306-4522(96)00062-0","article-title":"The effects of clozapine and haloperidol on serotonin-1A\u20132A and 2C receptor gene expression and serotonin metabolism in the rat forebrain","volume":"73","author":"Burnet","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2005.06.010_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004583-199401000-00002","article-title":"Sensory phenomenon associated with Gilles de la Tourette's syndrome","volume":"33","author":"Cohen","year":"1994","journal-title":"J Am Acad Adolesc Psychiatry"},{"key":"10.1016\/j.pbb.2005.06.010_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0091-3057(94)00340-8","article-title":"Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI","volume":"50","author":"Darmani","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2005.06.010_bib13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0031-9384(96)00323-X","article-title":"Differential ontogenesis of the DOI-induced behavior in mice","volume":"60","author":"Darmani","year":"1996","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pbb.2005.06.010_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2003.01693.x","article-title":"The cortical serotonin 2A receptor and the pathology of schizophrenia: a likely accomplice","volume":"85","author":"Dean","year":"2003","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.pbb.2005.06.010_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ajmg.a.20631","article-title":"Association between 7q31 markers and Tourette syndrome","volume":"127A","author":"Diaz-Anzaldua","year":"2004","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pbb.2005.06.010_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s002130050125","article-title":"Similarities in the pharmacology of spontaneous and DOI-induced head shakes suggest 5-HT2A receptors are active under physiological conditions","volume":"128","author":"Dursun","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2005.06.010_bib17","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(94)90388-3","article-title":"Long lasting improvement of Tourette's syndrome with transdermal nicotine","volume":"344","author":"Dursun","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2005.06.010_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130000558","article-title":"Effects of nicotine on head-shakes and tryptophan metabolites","volume":"153","author":"Gaynor","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2005.06.010_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s002130100801","article-title":"Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine","volume":"157","author":"Grottick","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2005.06.010_bib20","first-page":"235","article-title":"Serotonin and Tourette's syndrome: movements such as head-shakes and wet-dog shakes may model human tics","volume":"85","author":"Handley","year":"1992","journal-title":"Adv Biosci"},{"key":"10.1016\/j.pbb.2005.06.010_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pbb.2003.08.015","article-title":"Effects of donepezil on DOI-induced head twitch response in mice: implications for Tourette syndrome","volume":"76","author":"Hayslett","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2005.06.010_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.eurpsy.2003.11.002","article-title":"Clinical and attentional effects of acute nicotine treatment in Tourette's syndrome","volume":"19","author":"Howson","year":"2004","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pbb.2005.06.010_bib23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1476-5381.1994.tb14808.x","article-title":"In vivo properties of SB 200646A, a 5-HT2C\/2B receptor antagonist","volume":"111","author":"Kennett","year":"1994","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.pbb.2005.06.010_bib24","first-page":"747","article-title":"Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist\/5-HT2A\/2C antagonist anxiolytics. Drug discrimination and behavioral observation studies in rats","volume":"282","author":"Kleven","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.06.010_bib25","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(02)11526-1","article-title":"Tourette's syndrome","volume":"360","author":"Leckman","year":"2002","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2005.06.010_bib26","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0387-7604(03)90004-0","article-title":"Phenomenology of tics and natural history of tic disorders","volume":"25","author":"Leckman","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.pbb.2005.06.010_bib27","first-page":"15","article-title":"Pathogenesis of Tourette syndrome","volume":"58","author":"Leckman","year":"1992","journal-title":"Adv Neurol"},{"key":"10.1016\/j.pbb.2005.06.010_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0893-133X(94)00070-G","article-title":"CSF biogenic amine in OCD and TS","volume":"12","author":"Leckman","year":"1995","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2005.06.010_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1469-7610.1997.tb01508.x","article-title":"Pathogenesis of Tourette syndrome","volume":"38","author":"Leckman","year":"1997","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.pbb.2005.06.010_bib30","first-page":"301","article-title":"[3H] Ketanserin, a selective radioligand for 5-HT2 receptor binding sites","volume":"21","author":"Leysen","year":"1981","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2005.06.010_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(89)90409-3","article-title":"Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment","volume":"163","author":"Leysen","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.06.010_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/PL00005075","article-title":"Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907","volume":"356","author":"Lopez-Gimenez","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"Suppl. 2","key":"10.1016\/j.pbb.2005.06.010_bib33","first-page":"535","article-title":"The neurological basis of obsessive\u2013compulsive disorder and Tourette syndrome","volume":"80","author":"Mercadante","year":"2004","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.pbb.2005.06.010_bib34","first-page":"793","article-title":"Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder","volume":"148","author":"McConville","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2005.06.010_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0024-3205(84)90334-5","article-title":"Reduction of serotonin-2 receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof","volume":"34","author":"Mikuni","year":"1984","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2005.06.010_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2003.12.006","article-title":"Increased prefrontal D2 protein in Tourette syndrome: postmortem analysis of frontal cortex and striatum","volume":"219","author":"Minzer","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pbb.2005.06.010_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/syn.890060205","article-title":"Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain","volume":"6","author":"O'Dell","year":"1990","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2005.06.010_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-2999(01)00939-6","article-title":"Effects of 5-HT1A and 5-HT2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment","volume":"420","author":"Olausson","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.06.010_bib39","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/brain\/awh473","article-title":"Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine","volume":"128","author":"Orth","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.pbb.2005.06.010_bib40","first-page":"154","article-title":"A family study of Gilles de la Tourette syndrome","volume":"48","author":"Pauls","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pbb.2005.06.010_bib41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archpsyc.1985.01790310077011","article-title":"A twin study of Tourette syndrome","volume":"42","author":"Price","year":"1985","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2005.06.010_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(96)00199-4","article-title":"Nicotine for the treatment of Tourette's syndrome","volume":"74","author":"Sanberg","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2005.06.010_bib43","first-page":"101","article-title":"DOI-induced head twitches in the rat are mediated by 5-HT2A receptors","volume":"273","author":"Schreiber","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.06.010_bib44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/(SICI)1098-2299(199607\/08)38:3\/4<290::AID-DDR18>3.0.CO;2-2","article-title":"Transdermal nicotine for Tourette's syndrome","volume":"38","author":"Shytle","year":"1996","journal-title":"Drug Dev Res"},{"issue":"12","key":"10.1016\/j.pbb.2005.06.010_bib45","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/00004583-199612000-00015","article-title":"Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome","volume":"35","author":"Silver","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9","key":"10.1016\/j.pbb.2005.06.010_bib46","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4088\/JCP.v62n0908","article-title":"Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study","volume":"62","author":"Silver","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2005.06.010_bib47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0733-8619(05)70318-2","article-title":"Neurobiology of Tourette syndrome","volume":"15","author":"Singer","year":"1997","journal-title":"Neurol Clin N Amer"},{"key":"10.1016\/j.pbb.2005.06.010_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0387-7604(03)90012-X","article-title":"Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities","volume":"25","author":"Singer","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.pbb.2005.06.010_bib49","first-page":"484","article-title":"Adaptation of brain 5-HT2 receptors after mianserin treatment","volume":"254","author":"Smith","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.06.010_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s002130051000","article-title":"Mechanism of tolerance development to DOI in rats","volume":"144","author":"Smith","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2005.06.010_bib51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.neuropharm.2004.04.020","article-title":"The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors","volume":"47","author":"Steward","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2005.06.010_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130100866","article-title":"Cessation of chronic nicotine administration enhances wet-dog shake responses to 5-HT2 receptor stimulation in rats","volume":"159","author":"Suemaru","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2005.06.010_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2005.05.003","article-title":"Using animal models to develop therapeutics for Tourette syndrome","author":"Swerdlow","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2005.06.010_bib54","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0278-5846(01)00194-4","article-title":"Nicotine attenuates DOI-induced head twitch response in mice: implications for Tourette syndrome","volume":"25","author":"Tizabi","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2005.06.010_bib55","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/302613","article-title":"A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome","volume":"65","author":"Tourette Syndrome Association International Consortium for Genetics","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pbb.2005.06.010_bib56","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-3956(99)00006-0","article-title":"Regulation of glucocorticoid receptor mRNA in human blood cells by amitryptiline and dexamethasone","volume":"33","author":"Vedder","year":"1999","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pbb.2005.06.010_bib57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0278-5846(99)00014-7","article-title":"Selectivity of action of typical and atypical antipsychotic drugs as antagonists of the behavioral effects of DOI","volume":"23","author":"Wettstein","year":"1999","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2005.06.010_bib58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0006-8993(89)90833-0","article-title":"Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5HT2) and dopamine (D2) receptors in the rat brain","volume":"487","author":"Wilmot","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2005.06.010_bib59","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/002215549804600704","article-title":"Development and characterization of monoclonal antibodies specific to the serotonin 5-HT2A receptor","volume":"46","author":"Wu","year":"1998","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.pbb.2005.06.010_bib60","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0006-8993(02)03174-8","article-title":"Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase","volume":"951","author":"Xu","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2005.06.010_bib61","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1248\/bpb.18.1580","article-title":"Serotonin2 (5-HT2) receptor agonist 1-(2, 5-dimethoxy-4-idophenyl)-2-aminopropane (DOI) inhibits chlorpromazine- and haloperidol-induced hypothermia in mice","volume":"11","author":"Yamada","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pbb.2005.06.010_bib62","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00210-002-0592-4","article-title":"Effect of nicotine cessation on the central serotonergic systems in mice: involvement of 5-HT2 receptors","volume":"366","author":"Yasuda","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305705002157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305705002157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T11:22:06Z","timestamp":1548328926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305705002157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0091305705002157"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2005.06.010","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}